Kripthonite Therapeutics
PrivateLast Round
Pre Seed
May 1, 2025
Total Funding Raised
$110,000
Company Overview
Kripthonite Therapeutics is a biotechnology company that develops hypoxia-targeted cancer treatments designed to eliminate treatment-resistant cancer cells in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kripthonite Therapeutics Comparables
Compare Kripthonite Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Convert Pharmaceuticals | 77% | |
| Curve Therapeutics | 73% | |
| Orbis Medicines | 71% |
Kripthonite Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Raised a Pre Seed round with Marigold Maturation Fund.
Kripthonite Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kripthonite Therapeutics's valuation, stock price, and market status.
Is Kripthonite Therapeutics a public or private company?
Kripthonite Therapeutics is a private company.
What is the current stock price of Kripthonite Therapeutics?
Kripthonite Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kripthonite Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kripthonite Therapeutics worth (valuation)?
Valuation information for Kripthonite Therapeutics is not publicly available.
Can I buy Kripthonite Therapeutics stock?
Kripthonite Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kripthonite Therapeutics's last funding round?
Kripthonite Therapeutics's most recent funding round was Pre Seed on May 1, 2025.
Who are the main investors in Kripthonite Therapeutics?
Investor information for Kripthonite Therapeutics is not publicly disclosed.
Will Kripthonite Therapeutics IPO soon?
No public IPO plans have been announced for Kripthonite Therapeutics.
How can I track Kripthonite Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kripthonite Therapeutics's shares on secondary markets.